Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling

Noraida Mohamed Shah1, Ahmed F Hawwa, Jeff S Millership

  • 1Clinical and Practice Research Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast, United Kingdom.

Epilepsia
|March 2, 2013
PubMed

Insights

Adherence to antiepileptic drugs (AEDs) in children with epilepsy was assessed using multiple methods. Nonadherence was observed in 33% of children, with generalized epilepsy and parental depressed mood being significant predictors.

Area of Science:

  • Pediatric Neurology
  • Pharmacology
  • Clinical Pharmacy

Background:

  • Epilepsy affects a significant number of children worldwide.
  • Adherence to antiepileptic drugs (AEDs) is crucial for effective seizure management.
  • Accurate assessment of AED adherence in pediatric populations remains challenging.

Purpose of the Study:

  • To evaluate antiepileptic drug (AED) adherence in children with epilepsy.
  • To compare multiple adherence assessment methods, including novel dried blood spot (DBS) analysis.
  • To identify factors associated with nonadherence in pediatric epilepsy.

Main Methods:

  • A cohort of 100 children (≤17 years) with epilepsy was studied.
  • Adherence was measured via self-reporting, prescription refills, and AED concentrations in dried blood spot (DBS) samples.
  • Population pharmacokinetic modeling was used for DBS analysis; nonadherence was defined by any method indicating poor adherence.

Main Results:

  • The overall rate of nonadherence to AEDs was 33% in the studied children.
  • Children with generalized epilepsy (OR 4.7) and those with parental depressed mood (OR 3.6) were significantly more likely to be nonadherent.
  • Parental and child self-reporting, GP refill data, and DBS concentrations were utilized for adherence determination.

Conclusions:

  • This study introduces a novel methodology using clinic and home-based DBS samples for AED adherence assessment in children.
  • Dried blood spot (DBS) analysis, when further developed and combined with other methods, shows promise for adherence monitoring.
  • Seizure type and parental mental health (depressed mood) are significant predictors of medication nonadherence in pediatric epilepsy.
Abstract

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...